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A B S T R A C T
Mitochondrial morphology, which is associated with changes in metabolism, cell cycle, cell development and
cell death, is tightly regulated by the balance between fusion and fission. In this study, we found that S6 kinase 1
(S6K1) contributes to mitochondrial dynamics, homeostasis and function. Mouse embryo fibroblasts lacking
S6K1 (S6K1-KO MEFs) exhibited more fragmented mitochondria and a higher level of Dynamin related protein 1
(Drp1) and active Drp1 (pS616) in both whole cell extracts and mitochondrial fraction. In addition, there was no
evidence for autophagy and mitophagy induction in S6K1 depleted cells. Glycolysis and mitochondrial re-
spiratory activity was higher in S6K1-KO MEFs, whereas OxPhos ATP production was not altered. However,
inhibition of Drp1 by Mdivi1 (Drp1 inhibitor) resulted in higher OxPhos ATP production and lower mi-
tochondrial membrane potential. Taken together the depletion of S6K1 increased Drp1-mediated fission, leading
to the enhancement of glycolysis. The fission form of mitochondria resulted in lower yield for OxPhos ATP
production as well as in higher mitochondrial membrane potential. Thus, these results have suggested a potential
role of S6K1 in energy metabolism by modulating mitochondrial respiratory capacity and mitochondrial mor-
phology.
1. Introduction
Mitochondria are critical cellular organelles, best known for their
role in providing efficient energy support through the chemiosmotic
process of oxidative phosphorylation (OxPhos). In the 1960s, their role
in aerobic energy transduction through the characteristic chemiosmotic
mechanism of OxPhos first began to be clarified [1,2]. Since then, mi-
tochondria have also been shown to perform a variety of roles in pro-
cesses such as the transduction of metabolic and stress signals [2–5],
the production of free radicals such as reactive oxygen species (ROS)
[4,6], and the induction of programmed cell death [2,5,7]. The accu-
mulation of damaged mitochondria can be unfavorable to cells.
Mitochondrial quality and quantity are therefore strictly monitored to
ensure balanced cell physiology. Damaged or unwanted mitochondria
can be selectively removed by mitochondrial autophagy or mitophagy,
a catabolic process for lysosome-dependent degradation. The molecular
mechanism of mitophagy has begun to emerge. Several mitophagy re-
ceptors have been reported, including: ATG32 in yeast [8,9], NIX/
BNIP3L [10], BNIP3 [11], fun14 domain-containing protein 1
(FUNDC1) in mammalian cells [12] interacting with LC3 via their
conserved LC3 interaction region for mitophagy. E3 ubiquitin ligase
Parkin and phosphatase and tensin homolog (PTEN)-induced putative
protein kinase 1 (PINK1) also have critical functions for the removal of
depolarized mitochondria [13,14].
https://doi.org/10.1016/j.cellsig.2018.04.002
Received 16 January 2018; Received in revised form 5 April 2018; Accepted 13 April 2018
⁎ Correspondence to: Kwang Pyo Kim, Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University,
Yongin, 17104
⁎⁎ Corresponding authors.
E-mail addresses: kimkp@khu.ac.kr (K.P. Kim), mchotox@snu.ac.kr (M.-H. Cho), insulin@cnu.ac.kr (J. Park).
Cellular Signalling 48 (2018) 13–24
Available online 17 April 2018
0898-6568/ © 2018 Published by Elsevier Inc.
T
Mitochondrial functional flexibility is matched by their morpholo-
gical and structural change. During the lifetime of a cell, the mi-
tochondrial network is continuously shaped by fission and fusion events
[15]. Proteins involved in both the regulation and maintenance of mi-
tochondrial morphology have crucial roles in maintaining the health of
the cell [16,17]. The dynamin-related GTPases optic atrophy 1 (OPA1)
of the inner mitochondrial membrane [18], and mitofusins (MFN) 1 and
2 of the outer membrane [19] regulate mitochondrial fusion in mam-
malian cells. Reversely, the master regulator of mitochondrial fission is
a cytosolic member of the dynamin family of GTPases termed Drp1
(Dynamin-related protein 1). Drp1 polymerises around mitochondria,
and through GTP hydrolysis constricts the mitochondria leading to
membrane scission [20,21]. Drp1 activity at the mitochondrial outer
membrane is regulated by not only interactions with mitochondrial
accessory and effector proteins such as MFF, Fis1 [24] but also by post-
translational such as phosphorylation [23,24].
Ribosomal S6 kinase 1 (S6K1), a member of the AGC family of
serine/threonine protein kinases [25,26] has been linked to diverse
cellular processes, including protein synthesis, mRNA processing, glu-
cose homeostasis, cell growth and survival. S6K1 activity plays in a
number of pathologies, including obesity, diabetes, ageing and cancer
[27]. In 2004, Um et al. showed that S6K1 depletion increased UCP
expression and resulted in protecting mice from diet-induced obesity
[28]. However, as part of that protective phenotype, the morphology as
well as the activity of mitochondria, which tightly link nutrient utili-
zation and energy expenditure [29], were not elucidated. In this report,
we demonstrated that the depletion of S6K1 induced mitochondrial
fission but not mitophagy. These changes in mitochondrial morphology
alter the function of mitochondria, disrupting the balance of OxPhos
ATP production and shifting cellular energy metabolism. These data
provide new insights into the role of S6K1 in mitochondrial biology and
cellular energy regulation.
2. Materials and methods
2.1. Antibodies and reagents
Anti-Drp1 (#611112), anti-Rip1 (#610459) and anti-Opa1
(#612606) antibody were purchased from BD Biosciences (San Jones,
USA). Anti-LC3B (#L7543), anti-Actin (#A5316) anti-Fis1 (#PA5-
22142) antibodies were from Sigma-Aldrich (St. Louis, USA), anti-
pDrp1 (pS616 (#3455S) or pS637 (#58675)) were purchased from Cell
Signaling Technology (Boston, USA), anti-Tom40 (#SC-11414), and
anti-S6K1 (#SC230) were obtained from Santa Cruz Biotechnology
(Texas, USA). Anti-normal IGG (#L7543) and Horseradish peroxidase-
conjugated anti-mouse IgG (#K0211589) or anti-rabbit IgG
(#K0211708) secondary antibodies were from Komabiotech (Seoul,
Korea). Alexa flour 488 anti-rabit antibody was purchased from
Invitrogen (Oregon, USA). Anti-MFN2 (#ab56889) was from Abcam
(Cambridge, United Kingdom). Carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP), 2-deoxy-D-glucose (2DG), dichloroacetic acid (DCA),
oligomycin and other chemicals for OxPhos activity assay were pur-
chased from Sigma-Aldrich (St. Louis, USA). ATP assay kit was pur-
chased from Invitrogen (Oregon, USA).
2.2. Cell culture and stimulation
S6K1-WT MEFs and S6K1-KO MEFs were maintained in medium
(DMEM) supplemented with 10% FBS, 1% Antibiotics-Antimycotics
(Heathcare life sciences, Utah, USA). These cells were transfected using
Lipofectamine (Invitrogen, Oregon, USA) and jet-PEI (Polyplus, New
York, USA) reagents following the instructions provided by manu-
facturers. Cells were treated with 30 μM CCCP for 8 h, 25mM 2DG for
3 h, 30mM DCA for 3 h and 2 μM oligomycin for 3 h before the ATP
measurement.
2.3. Immunoblot analysis
The western blot analysis was performed as the described previously
[30,31]. After the completion of experimental conditions, cells were
placed on ice and extracted with lysis buffer containing 50mM Tris-
HCl, pH 7.5, 1% v/v Nonidet P-40, 120mM NaCl, 25mM sodium
fluoride, 40mM β-glycerol phosphate, 0.1 mM sodium orthovanadate,
1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM benzamidine, and
2 μM microcystin-LR. Lysates were centrifuged for 15min at 12,000 g.
The cell extracts were resolved by 15, 12 and 10% SDS-PAGE, and
transferred to Immobilon-P membranes (Millipore, Darmstadt, Ger-
many). The filters were blocked for 1 h in 1× tri-buffered saline buffer
(TBS; 140mM NaCl, 2.7 mM KCl, 250mM Tris-HCl, pH 7.4), containing
5% skimmed milk and 0.2% Tween-20, followed by an overnight in-
cubation with the primary antibodies diluted 1000 folds at 4 °C. The
secondary antibody was horseradish peroxidase-conjugated anti-mouse
IgG or anti-rabbit IgG (Komabiotech, Seoul, Korea), diluted 5000-fold
in the blocking buffer. The detection of protein expression was visua-
lized by enhanced chemiluminescence, according to the manufacturer's
instructions (Healthcare life sciences, Utah, USA).
2.4. Confocal imaging analysis
Cells were grown on glass coverslips until they were 50–70% con-
fluent and then transfected with pDsRed2-Mito, GFP-Parkin-WT or GFP-
LC3B constructs by using jet PEI reagents. After 48 h, the cells were
fixed in 4% paraformaldehyde and permeabilized in 0.2% Triton-×100
for 5min at room temperature. Then the coverslips were mounted with
Vectashield mounting solution (Vector Laboratories, Burlingame, USA),
and visualized using a Zeiss confocal microscope. For immune fluor-
escence staining, after fixation and permeabilization, cells were block
with 3%BSA in PBS for 2 h at room temperature followed by an over-
night incubation with the primary antibodies (p616-Drp1) diluted 100
folds at 4 °C. The secondary antibody was, Alexa flour 488 anti-rabbit
antibody, diluted 100-fold in the blocking buffer. Then the coverslips
were mounted with Vectashield mounting solution (Vector
Laboratories, Burlingame, USA), and visualized using confocal micro-
scope.
2.5. Immunoprecipitation
HEK293 cells were transfected with pCDNA3.1 Empty vector or
pCDNA3.1-Myc-S6K1 for 24 h, then placed on ice and extracted with
lysis buffer containing 50mM of Tris-HCl (pH 7.5), 0.5% v/v Nonidet P-
40, 250mM of NaCl, 3 mM of EDTA (pH 8.0), 3 mM of EGTA (pH 8.0),
40mM of h-glycerol phosphate, 0.1 mmol/L of sodium orthovanadate,
1 mmol/L of phenylmethylsulfonyl fluoride, 1 mmol/L of benzamidine,
and 2 μmol/L of microcystin-LR. S6K1 protein was immunoprecipitated
from 1000 μg of cell-free extracts with normal IgG or anti-S6K1 anti-
body. The immune complexes were washed three times separated on
SDS-PAGE and processed immunoblotting with anti-Rip1 antibody.
2.6. Flow cytometry (FACS) analysis for mitochondrial membrane potential
and mass
S6K1-WT MEFs and S6K1-KO MEFs were plated for 24 h. Then cells
were collected by trypsinization and stained with mito-green, JC-1
(Molecular probes, Invitrogen) for 30min in turn in order to measure
mitochondrial mass and mitochondrial membrane potential. The cells
then were washed and analyzed with mission filters by BD FACS Canto
system (BD Biosciences, San Jones, USA). For mito-green tracker: FITC
value represent for mitochondrial mass. For JC-1 set: the cells were
analyzed using 488 nm excitation with 530/30 nm and 585/42 nm
bandpass emission filters; JC-1 can selectively enter into mitochondria
and reversibly change color from red to green as the membrane po-
tential decreases. With high mitochondrial ΔΨm, JC-1 spontaneously
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forms J-aggregates exploring intense red fluorescence. With low ΔΨm,
JC-1 remains in the monomeric form, which shows only green fluor-
escence. The mitochondrial membrane potential is represented as a
ratio of PE/FITC value. Cells were treated with 30 μM CCCP for 10min
as a positive control to induce mitochondrial depolarization before
staining with the dye.
2.7. Transmission electron microscopy
S6K1-WT MEFs and S6K1-KO MEFs were fixed in a solution of 2.5%
glutaraldehyde with 1% osmium oxide (OsO4) buffer for 1 h at 4 °C,
dehydrated with ethanol at 4 °C. Then cells were infiltrated in a 1:1
mixture of propylene oxide and Epon and finally embedded in Epon by
polymerization at 60 °C for 48 h. Ultrastructural analyses were per-
formed on a SPIRIT G2 electron microscope.
2.8. Measurement of lactate in the culture medium
S6K1-WT MEFs and S6K1-KO MEFs were plated in 6-well plate, then
after 24 h cultured media were harvested and filtered through a 10 kDa
cut-off spin filter for lactate sample. The assays were measured ac-
cording to the manufacturer's instructions (lactate assay kit, Sigma-
Aldrich, Louis, USA).
2.9. Isolation of mitochondria and mitochondrial proteomic analysis
Cells were washed with PBS and suspended in mitochondrial frac-
tionation buffer (20mM Hepes, pH 8.0, 10mM KCl, 1.5 mM MgCl2,
1mM EDTA, 250mM sucrose, 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml
aprotinin, and 0.2 mM sodium orthovanadate) for 15min on ice and
then homogenized using 1ml syringe. Unbroken cells and nuclei were
pelleted by centrifugation at 800 g for 10min at 4 °C. The supernatant
was continuously centrifuged at 17,000 g for 10min at 4 °C and the
supernatant was transferred to a new tube to be used as a cytosolic
fraction. The pellet was washed with 500 μl of mitochondrial fractio-
nation buffer, and used as isolated mitochondrial fraction. The mi-
tochondrial fraction was analyzed by western blotting or OxPhos ac-
tivity assay. At the same time, mitochondrial fraction was used for
proteomic analysis.
2.10. Preparation of mitochondrial sample for proteomic analysis
Mitochondria protein digestion were performed by filter-aided
sample preparation method [32]. Briefly, protein samples (100 μg)
were reduced by adding SDT lysis buffer (4% sodium dodecyl sulfate
(SDS) and 0.1M dithiothreitol in 0.1M Tris-HCl, pH 7.6) and trans-
ferred to the filtration devices (Microcon devices, YM-30, Millipore,
MA). SDS from the proteins was washed with urea solution (0.2 ml of
8M urea in 0.1M Tris–HCl, pH 8.5) using centrifugation, followed by
alkylation with 50mM iodoacetamide in urea buffer solution. Filters
were washed three times with ureic acid buffer followed by washes
with 40mM NH4HCO3. Protein digestion was conducted overnight with
trypsin. After the first digestion, the second digestion was performed
using trypsin for 6 h [33]. The eluted tryptic peptides were fractionated
by isoelectrofocusing (IEF) fractionation, the 3100 OFFGEL fractionator
with a “Low Resolution Kit” pH 3–10 (Agilent Technologies, Santa
Clara, USA) according to the manufacturer's instructions.
2.11. Protein identification by liquid chromatography tandem-mass
spectrometry (LC-MS/MS)
The desalted and fractionated peptides were analyzed using the Q-
Exactive orbitrap hybrid mass spectrometer (Thermo Fisher Scientific,
Bremen, Germany) coupled with an EASY-nLC 1000 system (Thermo
Fisher Scientific, Bremen, Germany). Peptides were separated on a
50 cm×75 μM ID packed with 2 μM C18 particles (Easy spary column)
with a 220min gradient of solvent B (100% CAN, 0.1% formic acid)
form 5% to 40%. Survey MS scans (300–2000 Th) were acquired at a
resolution of 70,000 (at m/z 200) with an automated gain control
(AGC) target value of 1.0× 106 and a maximum ion injection of 20ms.
The maximal ion injection time for MS/MS was set to 60ms at a re-
solution of 17,500. Dynamic exclusion times were set to 30 s.
2.12. Raw data processing for mass spectrometrical (MS) analysis
The MS/MS spectra were searched with open source software
MaxQuant (v. 1.5.1.2) [34] against the Uniprot-human-reference (re-
leased in April 2014). A false discovery rate (FDR) cutoff of 1% was
applied at the proteins and peptides with minimum peptide length of 7
amino acids. Cysteine carbamidomethylation was set as fixed mod-
ification, whereas N-terminal protein acetylation and methionine oxi-
dation were set as variable modifications. The software MaxLFQ, a
generic method for label-free quantification was used for relative
quantification [35]. In addition, the “match between runs” feature was
implemented to increase the number of peptides that can be used for
quantification. We stringently filtered our data by requiring a minimum
peptide ratio count of 2 in MaxLFQ. Statistical analysis was carried out
by Perseus software (v.1.5.0.31, http://www.perseus-framework.org).
Each LFQ intensities were transformed by log2 values. Statistical
quantification analysis of log-transform data was performed using two
sample t-test (p value < 0.05). Additionally, in case missing value was
existed, we performed the relative quantification of proteins extracted
from one group which have a missing value and average of other group
which have no missing value. Consequently, Proteins with expression
greater than ± 1.5 fold change were added to differentially expressed
proteins (DEP). The resulting significant differentially expressed pro-
teins were analyzed for further annotation enrichments using DAVID
software exploring cellular processes, pathways, and biological pro-
cesses.
2.13. Measurement of enzyme activity of mitochondrial respiratory chain
Mitochondrial complexs activity were measured as previously de-
scribed [36,37]. To prepare sub-mitochondrial particles, isolated mi-
tochondrial pellets were suspended in hypotonic buffer (25mM po-
tassium phosphate, pH 7.2, 5 mM MgCl2) and then frozen and thawed
for three times. The mitochondrial protein concentration was measured
using the Bradford assay with BSA as a standard. Complex I activity
(NADH:CoQ oxidoreductase) was measured in the presence of decylu-
biquinone as the rotenone-sensitive decrease in NADH at 340 nm. The
activity of Complex II (succinate:DCIP oxidoreductase) was measured in
the presence of decylubiquinone plus rotenone as the antimycin A-
sensitive reduction of 2,6-DCIP at 600 nm, with 520 nm as the reference
wavelength. Complex III activity (Ubiquinol: cytochrome C oxidor-
eductase) was measured in the presence of rotenone and decylubiquinol
following the rate of reduction of cytochrome C at 550 nm, with 580 nm
as the reference wavelength. Complex IV activity (Cytochrome C oxi-
dase) was measured as the disappearance of reduced cytochrome C at
550 nm. All absorbance measurements were performed in a Beckman
DU650 (Beckman Coulter, Fullerton, CA) spectrophotometer. Complex
V is assayed in the reverse direction, as F1-ATPase. The assay relies on
linking the ATPase activity to NADH oxidation. Complex V activity was
measured in as the change in NADH at 340 nm absorbance.
2.14. Blue native polyacrylamide gel electrophoresis (BN-PAGE)
BN-PAGE was performed using the NativePAGE Novex® Bis-Tris Gel
system (Invitrogen) according to the manufacturer's instructions.
Briefly, 50 μg of isolated mitochondria was solubilized using
NativePAGE sample buffer supplemented with 0.5% n-dodecyl-β-D-
maltoside. After 30min incubation on ice, the suspensions were cen-
trifuged at 20,000×g for 10min at 4 °C. The resulting supernatants
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were loaded onto a NativePAGE Novex 3–12% Bis-Tris gel. After run-
ning, the gel was transferred to a PVDF membrane using the iBlot TM
Gel Transfer System (Invitrogen). The membrane was fixed with 8%
acetic acid and washed with distilled water. After overnight drying, the
membrane was de-stained with methanol and incubated in blocking
solution for 30min at room temperature. For BN-PAGE, the Anti-
OXPHOS Complex Kit (Invitrogen) primary antibody cocktail was used.
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Fig. 1. Morphological changes of mitochondria in S6K1-WT MEFs and S6K1-KO MEFs.(A) S6K1-WT MEFs and S6K1-KO MEFs were transiently transfected with
pDsRed–Mito for 48 h. Mitochondrial morphology of cells was monitored by using confocal microscopy. For positive control, S6K1-WT MEFs were treated with 30 μM
CCCP for 8 h. These results are a representative of three independent experiments. Scale bars represent 10 μM. (B) Fifty cells of each condition were counted and
quantified as the following. (Fragmented; mainly small and round mitochondria, Intermediate; mixture of round and tabulated mitochondria, Tubulated; long and
higher interconnected mitochondria). The results are mean ± S.D. of three independent experiments. Asterisk, p < 0.05; double asterisk, p < 0.01. (C)
Mitochondrial fraction from S6K1-WT MEFs and S6K1-KO MEFs were isolated. Regulatory proteins for mitochondria dynamics, fission -related (Drp1 and Fis1) and
fusion-related (Opa1 and MFN2) proteins were monitored by immunoblotting. These results are a representative of three independent experiments. (D) Relative
densities were obtained by densitometry. Relative expression of total protein was calculated by normalizing densitometric values to that of actin in each lane. For the
relative expression of mitochondria-localized protein were normalized with densitometric values of Tom40 in each lane. The results are mean ± S.D. of three
independent experiments. Asterisk, p < 0.05. (Tot: total, Mito: mitochondria). (E) S6K1-WT MEFs and S6K1-KO MEFs were transiently transfected with
pDsRed–Mito for 48 h. The cells were treated with 50 μM Nec-1 for 3 h and processed immune fluorescence assay to detect p616 Drp1. These results are a re-
presentative of three independent experiments. Scale bars represent 10 μM. (F) HEK293 cells were plated and transfected with empty control or pcDNA3.1 Myc-S6K1
vectors. After 48 h transfection, cells were harvested and followed by immunoprecipitation assay to check S6K1-Rip1 interaction. These results are a representative of
three independent experiments.
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washed and detected using the WesternBreeze® (Invitrogen)
Chromogenic Western Blot Immunodetection Kit according to the
manufacturer's instructions.
2.15. Analysis for oxygen consumption rate
The mitochondrial oxygen consumption rate (OCR) was measured
using a Seahorse XF-24 extracellular flux analyzer (Seahorse
Bioscience). On the day before the experiment, the sensor cartridge was
placed into the calibration buffer supplied by Seahorse Bioscience and
incubated at 37 °C in a non-CO2 incubator. MEFs were cultured on
Seahorse XF-24 plates at a density of 20,000 cells per well. Cells were
washed and incubated with assay medium (DMEM without bicarbo-
nate) at 37 °C in a non-CO2 incubator for 1 h. All media and injection
reagents were adjusted to pH 7.4 on the day of the assay. Three baseline
measurements of OCR were taken before sequential injection of mi-
tochondrial inhibitors. Three readings were taken after each addition of
mitochondrial inhibitor before injection of the subsequent inhibitors.
The mitochondrial inhibitors used were oligomycin (2 μg/ml), CCCP
(5 μM), and rotenone (1 μM). OCR was automatically calculated and
recorded by the Seahorse XF-24 software. After the assays, the plates
were saved, and protein levels were measured for each well to confirm
equal cell numbers per well. The percentage of change compared with
basal rates was calculated as the value of the change divided by the
average value of baseline readings.
2.16. ATP measurement
Cells were seeded in 12 well plate overnight. 2DG, 2DG+
Oligomycin were individually treated to the cells for 3 h then lysed the
cell with 100 ul of luciferase lysis buffer (Invitrogen). Reaction was
performed by adding 10 ul of samples into 90 ul of ATP solution-sup-
plied by Invitrogen and measured ATP level using Luminometer Lumat
LB 9507. By using 2-DG and oligomycin, the ratio of ATP production
between glycolysis-dependent and OxPhos system-dependent ATP
production was calculated. Oligomycin blocks proton channels, re-
sulting the inhibition of OxPhos system-dependent ATP production
while 2-DG blocks glycolysis-dependent ATP production. The in-
tracellular ATP were calculated as follows: Glycolytic ATP
(ATPgly)= total ATP− ATP2DG, OxPhos ATP under 2DG treatment
(ATPOxPhos)=ATP2DG−ATP2DG+Oligo.
2.17. Statistical analysis
Data are expressed as the mean ± S.E. from at least three separate
experiments. The differences between groups were analyzed using a
Student's t-test and P < 0.05 is considered statistically significant.
Quantitative analyses of the western blotting results were performed by
using Image J software (version 1.45).
3. Results
3.1. Mitochondrial fission is upregulated in S6K1 knockout mouse
embryonic fibroblast (MEFs)
Earlier studies [38] indicated that S6K1 regulates mitochondrial
dynamics in the HeLa cells. In order to further define this phenomenon
in the normal cells, S6K1-knockout (KO) MEFs were employed as pre-
viously described [39]. The mitochondria of S6K1-WT MEFs and S6K1-
KO MEFs were labeled with Mito-Red (pDs-Red Mito). As shown in
Fig. 1A, the mitochondrial fragmentation was elevated in S6K1-KO
MEFs compared to wild-type controls, and reached a level similar to
wild-type MEFs treated with CCCP a mitochondrial uncoupler, which is
a mitochondrial fragmentation inducer [40]. Based on the mitochon-
drial morphology, the cells were categorized as (1) fragmented-mainly
small and round mitochondria, (2) intermediate-mixture of round and
tubulated mitochondria or (3) tubulated-long and higher inter-
connected mitochondria (Fig. 1B). A marked increase in the number of
fragmented mitochondria was detected in S6K1-KO MEFs compared to
S6K1-WT MEFs indicating that the absence of S6K1 leads to mi-
tochondria fission in these cells. To further elucidate the link between
S6K1 and regulatory proteins for mitochondria dynamics, fission -re-
lated (Drp1 and Fis1) and fusion-related (Opa1 and MFN2) proteins
were characterized. Total Drp1 and mitochondria-localized Drp1 (a key
regulator of mitochondrial fission) were elevated in S6K1-KO MEFs
compared to S6K1-WT MEFs (Fig. 1C, top two panel, Fig. 1D). There
was no detectable changes of other regulatory proteins, suggesting that
Drp1 is involved in S6K1-medated mitochondrial dynamics.
It has been shown that the fission activity of Drp1 is tightly regu-
lated by phosphorylation [22]. Phosphorylation of Drp1 on Ser-616
activates Drp1 activity while Ser-637 phosphorylation inhibits [24].
Both whole-cell and mitochondrial extracts demonstrated higher levels
of Drp1 Ser-616 phosphorylation, suggesting that S6K1-regulted Drp1
activity may be important for mitochondria fission whereas Ser-637
phosphorylation of Drp1 was not altered in both conditions (Supple-
ment Fig. 1). The enhancement of Drp1-mediated fission was observed
by Rip1 activation previously {Wang, 2014 #186}. Nec-1, the kinase
inhibitor of Rip1 decreased Rip1-regulated Drp1 phosphorylation at
Serine 616, consequently leading to the defection in fission. In order to
evaluate the possibility if S6K1-mediated Drp1 regulation is dependent
on Rip1, immunofluorescence analysis of S6K1-WT MEFS and S6K1-KO
MEFs with anti-Ser-616 Drp1 antibody following Nec-1 treatment was
employed (Fig. 1E). The expression and mitochondrial localization of
phosphor-Ser-616 Drp1 were remarkable enhanced in S6K1 KO-MEFs,
indicating that S6K1 actually induced mitochondrial fission by in-
creasing Ser-616 Drp1 phosphorylation. As expected, the treatment of
cells with Nec-1 abolished the enhancement of phospho-Ser-616 Drp1
level as well as the mitochondrial co-localization in S6K1-KO MEFs.
Hence, S6K1 absence induced phosphor-Ser-616 Drp1 through Rip1
kinase activity. Furthermore, the immunoprecipitation assay revealed
that S6K1 bound to Rip1 in both endogenous and exogenous level
(Fig. 1F). Taken together, S6K1 interacted with Rip1 and regulate its
kinase activity. Once Rip1 is released from this complex such as S6K1
deletion, it phosphorylated Drp1 at serine 616, resulting in mitochon-
drial fission.
3.2. No detectable changes of autophagy and mitophagy was found in
S6K1-KO MEFs
Since mitochondrial fragmentation is considered as an early step of
autophagy and mitophagy, we examined changes in these processes in
our S6K1-KO MEFs [41]. Treatment of S6K1-WT MEFs with CCCP in-
duced the accumulation of LC3B-II, a marker of autophagy (Fig. 2A).
Basal levels of LC3B-II were not altered in S6K1-KO MEFs (Fig. 2A).
Importantly, LC3B-II accumulation also increased in these cells fol-
lowing CCCP treatment (Fig. 2A), suggesting that autophagy was not
altered by S6K1 depletion. In order to monitor mitophagy, staining for
mitochondrial localized- LC3 punctate was performed. There was no
detectable over-lapping signal for mitochondria (Mito-Red) and LC3
punctate staining in S6K-KO MEFs, similar to S6K1-WT MEFs (Fig. 2B).
Over-lapping staining was, however enhanced in S6K1-WT MEFs
treated with CCCP (Fig. 2C). Consistent with these results, mitochon-
drial recruitment of exogenously expressed GFP-Parkin was detected in
both S6K1-WT MEFs and S6K1-KO MEFs treated with CCCP (Fig. 2D
and E). Taken together, these data suggest that the depletion of S6K1
does not influence autophagy and mitophagy in MEFs, despite the en-
hanced mitochondrial fission in S6K1-KO MEFs.
3.3. Mitochondrial respiratory capacity is enhanced in S6K1-KO MEFs with
a reduction of mitochondrial mass
Mitochondrial morphology closely links with its capacity and
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function [29,42,43]. Therefore the mitochondrial function in S6K1-KO
MEFs was analyzed, since S6K1-KO MEFs demonstrated mitochondrial
fission without increased mitophagy (Figs. 1 and 2). Interestingly, mi-
tochondrial membrane potential (ΔΨm; mitochondrial respiratory ca-
pacity) was elevated in S6K1-KO MEFs compared to control cells
(Fig. 3A). The ΔΨm of both MEF subtypes was significantly reduced to
the similar extend following CCCP treatment (Fig. 3B). Transmission
electron microscopy (TEM) images of S6K1-KO MEFs showed less mi-
tochondria than S6K1-WT MEFs (Fig. 3C). Relative mitochondrial mass
of S6K1-KO MEFs was only 50 % in S6K1-WT MEFs (Fig. 3D and E).
These results indicated that mitochondrial respiratory capacity of S6K1-
KO MEFs was enhanced with the reduction of mitochondria mass,
compared to wild type MEFs, suggesting that mitochondria function is
actually elevated in the absence of S6K1. To test this hypothesis, in
vitro OxPhos activity and oxygen consumption rate were measured.
Using blue native polyacrylamide gel electrophoresis (BN-PAGE),
multiple complexes for OxPhos were not increased in S6K1-KO MEFs
(Fig. 3F). S6K1-KO MEFs exhibited higher OxPhos complex II activity
with no changes in complexes I, III, IV or V detected (Fig. 3G). In ad-
dition, the oxygen consumption rate (OCR) was enhanced in S6K1-KO
MEFs compared to S6K1-WT MEFs (Fig. 3H). These results suggested
that S6K1 depletion did not affect mitochondrial respiratory chain as-
sembly but was able to modulate the respiration activity which might
due to the changes in OxPhos components (subunit proteins, coacti-






























































































































Fig. 2. Effects of S6K1 on autophagy and mitophagy
in S6K1 WT MEFs and S6K1-KO MEFs. (A) S6K1-WT
MEFs and S6K1-KO MEFs were treated with 30 μM
CCCP for 8 h. Total cell lysate were analyzed by
western blot analysis with anti-LC3B and anti-actin
antibody (lower panel). The results represent the
levels of autophagy by calculating the intensity ratio
between LC3B-II and total LC3B. Relative intensity
of each band was calculated by normalizing densi-
tometric values to that of actin in each lane. The
results are mean ± S.D. of three independent ex-
periments. Asterisk, p < 0.05; double asterisk,
p < 0.01. (B) S6K1-WT MEFs and S6K1-KO MEFs
were cotransfected with Mito-Red and GFP-LC3B for
48 h. The samples was analyzed by confocal micro-
scope. Red fluorescence represented for mitochon-
dria, Green fluorescence represented for LC3B and
Blue fluorescence DAPI represented for nucleus.
These results are a representative of three in-
dependent experiments. Scale bars represent 10 μM.
(C) The results was calculated as a number of LC3B
puncta per cell (black bar), or merged LC3B puncta
with Mito-Red per cell (white bar). Fifty cells were
analyzed for each sample. The results are
mean ± S.D. of three independent experiments.
Asterisk, p < 0.05; double asterisk, p < 0.01. (D)
S6K1-WT MEFs and S6K1-KO MEFs were co-
transfected with Mito-Red and GFP-Parkin for 48 h.
The sample was analyzed by confocal microscope.
These results are a representative of three in-
dependent experiments. Scale bars represent 10 μM.
(E) The results was calculated as a number of
merged GFP-parkin puncta with Mito-Red per cell.
Fifty cells were analyzed for each condition. The
results are mean ± S.D. of three independent ex-
periments. Asterisk, p < 0.05; double asterisk,
p < 0.01. (For interpretation of the references to
color in this figure legend, the reader is referred to
the web version of this article.)
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3.4. Proteomic analysis for mitochondrial proteins supported the elevation
of mitochondrial respiratory capacity in S6K1-KO MEFs
Proteomic analysis of isolated mitochondria from S6K1-WT MEFs
and S6K1-KO MEFs has been performed to investigate the possible
mechanism how mitochondria function is elevated in S6K1-KO MEFs.
Following the analysis of identified proteins from mitochondrial frac-
tion of both cell types, as shown in the schematic diagram (Fig. 4A),
1372 mitochondrial proteins were identified among 4519 detectable
proteins (Fig. 4B, top panel) which were enriched for mitochondrial
proteins, confirming the integrity of the mitochondrial preparation
(Fig. 4B, bottom panel), indicating that mitochondrial fraction has been
prepared properly. Heat-map analysis of differentially expressed pro-
teins between S6K1-WT MEFs and S6K1-KO MEFs revealed that the
electron transport chain, oxidation-reduction, metabolic cofactors,
metabolic coenzymes and fatty acid metabolic proteins were highly
upregulated in mitochondria from S6K1-KO MEFs whereas proteins
involved in ATP metabolic process were down-regulated (Fig. 4C).
Furthermore, a network model of OxPhos complex subunits from the
detectable proteins of complexes (complex I: 34 proteins, complex II: 4
proteins, complex III: 7 proteins, complex IV: 10 proteins and complex
V: 24 proteins) showed that majority of subunit proteins in complex I,
II, III and IV were significantly increased (complex I: 68%, II: 75%, III:
86%, IV: 80%). Overall, these findings suggest that S6K1-KO MEFs
displayed a higher respiratory activity due to an elevation of OxPhos
component.
3.5. Glycolytic ATP production was increased while OxPhos ATP
production was not changed in S6K1-KO MEFs
Since mitochondrial activity were elevated in S6K1-KO MEFs, in-
tracellular ATP production was monitored by using several inhibitors as
described in the materials and methods. S6K1 depletion enhanced total
ATP levels compared to controls (Fig. 5A). Interestingly, glycolytic ATP
production was increased in S6K1-KO MEFs while OxPhos ATP pro-


























































































































































Fig. 3. Analysis of mitochondria-related parameters in S6K1 WT MEFs and S6K1-KO MEFs. (A) S6K1-WT MEFs and S6K1-KO MEFs were treated with or without
30 μM CCCP for 10min, followed by staining with JC-1 dye. Mitochondrial membrane potential was measured using flow cytometry. These results are a re-
presentative of three independent experiments. (B) Relative and statistical differences of mitochondrial membrane potential (ratio of Q2/Q3) was calculated and set
the values for S6K1-WT MEFs as 1. The results are presented as means ± S.D. of three independent experiments. Asterisk, p < 0.05; 0.0586, p= 0.058601. (C)
S6K1-WT MEFs and S6K1-KO MEFs were analyzed by Transmission Electron Microscopy. Black Arrows: mitochondria; N: nucleus. These results are a representative
of three independent experiments. Scale bars represent 2 μM. (D) The cells were stained MitoTracker Green FM dye for mitochondria mass. Mitochondria mass were
measured by flow cytometry. These results are a representative of three independent experiments. (E) Relative mitochondrial mass was calculated and set values for
S6K1-WT MEFs as 1. The results are presented as means ± S.D. of three independent experiments. Asterisk, p < 0.05; double asterisk, p < 0.01. (F) Mitochondrial
fraction was isolated from S6K1-WT MEFs and S6K1-KO MEFs. Samples were analyzed by using BN-PAGE to detect the each OxPhos complexes. (G) Isolated
mitochondria from both MEFs was incubated with the corresponding inhibitors to measure the each OxPhos-complex activity as the described in the materials and
methods. The results are mean ± S.D. of three independent experiments. Asterisk, p < 0.05. (H) S6K1-WT MEFs and S6K1-KO MEFs were plated in DMEM media
for 24 h. Oxygen consumption rate (OCR) was determined by using Seahorse XF-24 extracellular flux analyzer. The results are presented as means ± S.D. of three
independent experiments.
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Fig. 4. Comparison of mitochondrial proteomes
between S6K1-WT MEFs and S6K1-KO MEFs
(A) The schematic diagram for the proteomic
analysis of isolated mitochondria from S6K1-
WT MEFs and S6K1-KO MEFs. Isolated mi-
tochondria proteins were digested and analyzed
by Bench top orbitrap mass spectrometry (Q-
Exacitve). MaxLFQ, based on MS1 level quan-
tification, was used. (B) Enrichment of mi-
tochondria proteins from 3-known mouse mi-
tochondria proteome database were used for
the further analysis. The cellular component
proteins identified from proteomic analysis
were confirmed by DAVID bioinformatics tool.
The enrichment factors (count) were shown for
proteins from 1372 mitochondria proteins. (C)
Heat-map shows significant GO biological pro-
cess terms (p-value < 0.05) for differentially
expressed proteins between S6K1-WT mi-
tochondria and S6K1-KO mitochondria. Color
bar represents the gradient –log10 (p-value).The
term with red color indicates critical alteration
in S6K1-KO MEFs. Star markings show the most
enriched GO category in a heat-map. (D) A
network model of OxPhos complex subunits.
Almost all proteins of complex I (34-genes),
complex II (4-genes), complex III (7-genes),
complex IV (10 -genes) and complex V (24-
genes) were identified. Complex I-IV proteins
were upregulated overall and complex V don't
have distinctive direction of alteration. Color
bar indicates gradient of log2 fold change. All
are indicated by gene symbol. (For interpreta-
tion of the references to color in this figure le-
gend, the reader is referred to the web version
of this article.)
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observation, the pH of culture medium indicated that the medium of
S6K1-KO MEFs was more acidic than that of S6K1-WT MEFs (Fig. 5C).
As expected, the secretion of lactic acid was also increased in S6K1-KO
MEFs (Fig. 5D), indicating that the energy metabolism has been shifted
to glycolytic dependent pathways in S6K1-KO MEFs.
3.6. S6K1-mediated mitochondrial fission and mitochondrial functions were
positively regulated by Drp1 activity
Based on previous results (Figs. 3–5), elevated ΔΨm and mi-
tochondrial activity does not appear to contribute to OxPhos ATP
production in S6K1-KO MEFs. Therefore the possible involvement of
Drp1-regulated mitochondrial fission was examined by using Drp1 in-
hibitor, Mdivi1. Mitochondrial fission in S6K1-KO MEFs was blocked by
the treatment of cells with Mdivi1 (Fig. 6A). ΔΨm of Mdivi1-treated
S6K1-KO MEFs was also reduced (Fig. 6B), resulting to the elevation of
OxPhos ATP production (Fig. 6C), suggesting that Drp1 activity is re-
quired for S6K1 absence-mediated mitochondrial functions. Moreover,
treatment of Nec-1, a Rip1 inhibitor, which also inhibited Drp1-medi-
ated fission (Fig. 1E) exposed the similar mitochondrial recovery with
Mdivi1 treatment. After normalizing with non-treated cells respec-
tively, the relative ΔΨm in Nec-1 treated-S6K1 KO MEFs was only 0.6
while this value in Nec-1 treated-S6K1 WT MEFs was almost 1 (Fig. 6D).
Furthermore, Nec-1 treatment significantly increased OxPhos ATP in
S6K1 KO MEFs indicating for the elevation of coupling activity
(Fig. 6E).
4. Discussion
Mitochondria represent a key cellular organelles and utilize both
vital and lethal functions in physiological and pathological settings
[5,42–44]. The role of mitochondria in cell signaling and energy me-
tabolism is closely associated with its morphology. Fission, one of two
mitochondrial dynamic controlling processes was found to be upregu-
lated in S6K1-KO MEFs (Fig. 1). Fission is shown to be under control of
Drp1 modification as well as trans-localization of Drp1 [25]. S6K1 is a
member of the AGC family of serine/threonine protein kinases [45,46],
well known as an effector of mTOR in insulin and nutrient signaling
[38] as well as in many cellular processes including mRNA splicing and
transcription [45]. In addition, mitochondrial morphology and function
are tightly associated with obesity and diabetes [47,48]. Interestingly,
it has been reported that the absence of S6K1 in mice protected against
age- and diet-induced obesity with the enhancement of insulin sensi-
tivity [28]. However the morphological role of mitochondria in these
mice was not investigated in details. Here we reported that S6K1 de-
ficiency induced Drp1-mediated fission, thereby affecting the cellular
energy metabolism. Mitochondrial fission induced by S6K1 depletion
reduced the efficiency of OxPhos ATP production (Figs. 4 and 5), sug-
gesting that these events might be important mechanism to explain the
protective phenotype of S6K1-KO mice against obesity when they were
fed with high fat diet. Therefore these results have provided a new
insight into the role of S6K1 in regulating mitochondrial function and
structure in cells.
In the life cycle of mitochondria, it frequently is faced to the danger
condition such as ROS, mtDNA mutation, low mitochondrial membrane
potential and Ca2+ overload [49,50]. The mitochondrial quality con-
trol, mediated by mitophagy, is highlighted as an emerging topic in-
volved in cell development and diseases. In this process, mitochondrial
fission is considered as an earlier event, dividing weak mitochondria
into one healthy and one damage mitochondria, which recruits autop-
hagosome by conjugating with LC3. Consequently, damaged mi-
tochondria will be removed by fusing with lysosome [29]. Based on the
previous study [38] and Fig. 1, a question has been raised if S6K1-
mediated fission can consequently increase autophagy and mitophagy
since mTOR activity controlled the early stage of autophagy? However,
the autophagic and mitophagic events were not affected in S6K1-KO
MEFs (Fig. 2). Interestingly, ΔΨm, which is an indicator of healthy
mitochondria, was enhanced in S6K1-KO MEFs compared to S6K1-WT
MEFs (Fig. 3A and B), suggesting that S6K1 depletion was able to in-
























































































































Fig. 5. Effects of S6K1 depletion on the energy me-
tabolism (A) S6K1-WT MEFs and S6K1-KO MEFs
were plated and pretreated with 2DG or 2DG/
Oligomycin for 3 h. ATP level then was measured
using ATP kit guideline from Invitrogen. Glycolysis-
dependent ATP (Gly), OxPhos-dependent ATP
(OxPhos) and basal (Basal) ATP were calculated as
the described in the materials and methods. The
results are mean ± S.D. of three independent ex-
periments. (B) Proportion of ATP contribution was
calculated. 2DG-sensitive (glycolysis-dependent;
Gly) and Oligomycin-sensitive (OxPhos-dependent;
OxPhos) ATP production were indicated as a per-
centage of total cellular ATP level. (C) After 48 h
incubation of both MEFs, the acidification of cell
culture medium was imaged. These results are a
representative of three independent experiments.
(D) Lactate levels in culture-media were measured
by using lactate assay kit. The results are
mean ± S.D. of three independent experiments.
Asterisk, p < 0.05; double asterisk, p < 0.01.
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mitochondria even though the autophagy and mitophagy were not
occurred in these cells.
During the glucose metabolism, once glucose is imported to the cell,
it will be metabolized, then produce ATP and pyruvate in cytoplasm.
The flows of generated pyruvate form a junction. Pyruvate from gly-
colysis may turn into the lactate pathway. The enhancement of glucose
uptake and glycolysis leads to higher level of pyruvate, consequently
increase the activity of lactate pathway and lactic acid production. On
the other hand, cytosolic pyruvate may be entered to mitochondria via
pyruvate carriers and become a substrate for TCA cycle. In this regards,
S6K1-KO MEFs showed the preference of lactate metabolism (Fig. 5C
and D) to generate ATP without the alteration of OxPhos ATP pro-
duction (Fig. 5A) in these cells. Interestingly, the mitochondrial re-
spiratory capacity, monitored by OxPhos complex activity (Fig. 3G),
oxygen consumption rate (OCR; Fig. 3H) and proteomic analysis of
mitochondrial fraction (Fig. 4), were enhanced in S6K1-KO MEFs
compared to the control MEFs whereas the consequent OxPhos-de-
pendent ATP production was not changed (Fig. 5A). These observation
can be explained by the fission form of mitochondria which may have
lower ATP productive yield. Indeed, Molina and colleagues have shown
that hyperpolarized mitochondrial fission was also observed in the cells
with the nutrient overload [48]. Similarly, the elongated mitochondria
were found as a protection event against starvation [51,52]. These raise
a hypothesis that the changes of mitochondrial morphology are con-
sequent events of energy adaption. The balance of nutrient supply and
energy demand is associated with corresponding changes to mi-
tochondrial morphology and to bioenergetics efficiency [29]. Pre-
viously it has been reported that PKB activation, which can be elevated
by S6K1 absence [28], increased glucose uptake by modulating GLUT4
traffic [53,54]. High glucose uptake is considered as nutrient access
condition, which breaks the energetic balance, enhances the OxPhos
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Fig. 6. Reversion of mitochondrial functions by re-
turning the mitochondrial morphology in S6K1-KO
MEFs. (A) S6K1-KO MEFs were transiently trans-
fected with pDsRed–Mito for 48 h. The cells were
treated with 50 μM Mdivi-1 for 30mins.
Mitochondrial morphology of cells was monitored by
using confocal microscopy. These results are a re-
presentative of three independent experiments. Scale
bars represent 10 μM. (B) S6K1-KO MEFs were
treated with 50 μM Mdvidi-1 for 30mins or 30 μM
CCCP for 10mins, followed by staining of cells with
JC-1 dye. Mitochondrial membrane potential was
measured using flow cytometry. Relative and statis-
tical differences of mitochondrial membrane poten-
tial (ratio of Q2/Q3) were calculated and set the
values for untreated control as 1. The results are
mean ± S.D. of three independent experiments.
Asterisk, p < 0.05; double asterisk, p < 0.01. (C)
The cells were treated with 50 μM Mdivi-1 for
30mins. OxPhos-dependent ATP was measured as
the described previously. OxPhos ATP value in the
untreated cells was set as 1. The results are presented
as means ± S.D. of three independent experiments.
Asterisk, p < 0.05; double asterisk, p < 0.01. (D)
S6K1-KO MEFs were treated with 50 μM Nec-1 for 3
followed by staining of cells with JC-1 dye.
Mitochondrial membrane potential was measured
using flow cytometry. Relative and statistical differ-
ences of mitochondrial membrane potential (ratio of
PE/FITC) were calculated and set the values for un-
treated control in both S6K1 WT/KO MEFs as 1. The
results are mean ± S.D. of three independent ex-
periments. Asterisk, p < 0.05; double asterisk,
p < 0.01. (E) The cells were treated with 50 μM Nec-
1 for 3 h. OxPhos-dependent ATP was measured as
the described previously. OxPhos ATP value in the
untreated cells was set as 1. The results are presented
as means ± S.D. of three independent experiments.
Asterisk, p < 0.05; double asterisk, p < 0.01.
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these observations, S6K1-KO MEFs showed a higher mitochondrial fis-
sion (Fig. 1), a hyperpolization of ΔΨm (Fig. 3A and B) and an elevation
of total ATP level (Fig. 5A). In addition, Drp1 phosphorylation on S616
(the active form of Drp1) was appeared to be high in S6K1-KO MEFs
(Supplemental Fig. 1). Rip1, the upstream kinase which could phos-
phorylate Drp1 at Serine 616 interacted with S6K1. The elevations of
pS616 Drp1 level and its translocation to mitochondria in S6K1 KO
MEFs were depressed by treating with Nec-1 a kinase inhibitor of Rip1.
Furthermore the restoration of tubular form of mitochondria in S6K1-
KO MEFs by Mdivi1 treatment (Drp1inhibitor) or Nec-1 treatment (rip1
inhibitor) lead to decrease ΔΨm and increase OxPhos ATP production
(Fig. 6), indicating that S6K1 depletion-induced mitochondrial fission
event might be the molecular mechanism to maintain the hyperpoli-
zation of ΔΨm and reduce the efficiency of OxPhos-dependent ATP
production (Fig. 7). Taken together, these results have proposed a po-
tential role of S6K1 in energy metabolism by modulating mitochondrial
respiratory capacity and mitochondrial morphology.
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hibits Rip-mediated Drp1 phosphorylation at Serine
616. Once S6K1 is lacked, PKB is hyper activated
resulting in the enhancement of glycolysis. S6K1
absence facilitates Rip1-mediated Drp1 phosphor-
ylation, consequently increases mitochondrial Drp1
and mitochondrial fission. Fragmented mitochon-
dria maintained a high mitochondrial membrane
potential and reduced ATP production. Thus S6K1
deficiency increased glycolysis-dependent ATP pro-
duction but not OxPhos-dependent ATP production,
due to the change of mitochondrial morphology and
function. Recovery of tubular mitochondria by Nec-
1 or Mdvi1 in S6K1 KO MEFs also returns the mi-
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reduced mitochondrial membrane potential.
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